Peptides, explained
Sourced, plain-English, hype-free. New articles every week.
Retatrutide TRIUMPH-2 Results Explained (EASD 2026)
Full TRIUMPH-2 results for retatrutide in type 2 diabetes: up to 20.8% weight loss and A1C down up to 1.6 points at 80 weeks. What the numbers mean, plainly.
Read →Retatrutide vs Tirzepatide vs Semaglutide (2026)
Retatrutide, tirzepatide and semaglutide compared honestly: mechanism, trial weight loss, side effects, and the big difference: only two are FDA-approved today.
Read →What Is Retatrutide? The Triple-Agonist, Explained
Retatrutide is an investigational weekly injection that acts on three hormone receptors: GIP, GLP-1 and glucagon. How it works, what trials show, its status.
Read →When Will Retatrutide Be Available? The Real Timeline
Lilly plans to submit retatrutide to the FDA in Q1 2027. The realistic approval timeline, the early access program, and why "research" vials are not it.
Read →CJC-1295: What the Evidence Actually Shows in 2026
CJC-1295 is a long-acting GHRH analog discussed for growth hormone support. Here is the real human trial evidence, the safety history, and its current regulatory status.
Read →How Much Does GLP-1 Telehealth Cost in 2026? Wegovy, Zepbound & More
What semaglutide and tirzepatide actually cost via telehealth in 2026 — insured, manufacturer cash-pay programs, and bundled telehealth pricing — broken down plainly.
Read →GLP-1 Telehealth: How Online Weight-Loss Prescriptions Work in 2026
How GLP-1 telehealth actually works in 2026 — the intake, the licensed prescriber, what gets shipped, and how it differs from a site that skips the exam entirely.
Read →Ipamorelin: What the Evidence Actually Shows in 2026
Ipamorelin is a selective ghrelin receptor agonist discussed for growth hormone support. Here is what human research actually shows, the gaps, and its current regulatory status.
Read →PCAC Vote Results: 6 of 7 Peptides Recommended (BPC-157, TB-500 & More)
In July 2026 an FDA advisory committee recommended 6 of 7 peptides, including BPC-157 and TB-500, for the 503A Bulks List. Here are the votes and what comes next.
Read →BPC-157: What the Evidence Actually Shows in 2026
BPC-157 is one of the most-discussed recovery peptides — and one of the least studied in humans. Here is the real evidence, the gaps, and its current regulatory status.
Read →Compounded vs Brand-Name Semaglutide in 2026: What Changed
Mass compounding of semaglutide mostly ended in 2025. Here is what is still legally compounded, how brand-name pricing has shifted, and how to tell the two apart in 2026.
Read →Is BPC-157 Legal in 2026? The Honest, Current Answer
BPC-157 is not FDA-approved and not banned outright. Here is its actual regulatory status in 2026, what changed in April, and and what the July 2026 PCAC vote means.
Read →PCAC July 2026 Review Explained: BPC-157, TB-500 & More
On July 23–24, 2026 the FDA advisory committee weighs BPC-157, TB-500, MOTS-c, KPV, Semax, Epitalon, and DSIP. Here is what the meeting can and cannot change.
Read →Semaglutide vs Tirzepatide: The Honest 2026 Comparison
Semaglutide vs tirzepatide, compared plainly: how they differ, what the trials show for weight loss, cost, side effects, and how to think about choosing — no hype.
Read →TB-500: What the Evidence Actually Shows in 2026
TB-500 is discussed as a synthetic version of thymosin beta-4. Here is what human and animal research actually show, the gaps, and its current regulatory status.
Read →FDA Peptide Reclassification 2026: The Full List of What Actually Changed
In 2026 the FDA moved 12 peptides — including BPC-157 and TB-500 — off its restricted list. Here is what changed, what did not, and what the July PCAC review means, in plain English.
Read →Are GLP-1s Like Semaglutide Actually Peptides? (Yes — Here's How They Work)
Semaglutide and tirzepatide are the most famous molecules in medicine right now — and they are peptides. Here is what that means, how they work, and how they differ, in plain English.
Read →How to Get Peptides Prescribed: The Legitimate Path in 2026
A step-by-step, no-hype guide to accessing peptides the legal and safe way — through a licensed provider and a compounding pharmacy — plus what things cost and the red flags to avoid.
Read →